Aplitabart

IGM-8444 · IGM Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aplitabart, covering 2025-03-28 to 2025-03-28. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers [Phase 1]

See pricing